CME INDIA Presentation by Dr. Shambo Samrat Samajdar (JMN Medical College and Hospital, Nadia, West Bengal).

Quick Guide

1. Treating Gram-Positive Infections:

• First-line Options:

Penicillins: Penicillin G and V for sensitive Gram-positive infections.

Anti-Staphylococcal Penicillins: Dicloxacillin, Nafcillin, and Oxacillin for staphylococcal infections (except MRSA).

Resistant Gram-Positive Infections:

Vancomycin: For MRSA and resistant infections.

Linezolid and Tedizolid: Effective for MRSA and VRE.

Daptomycin: Useful for bloodstream infections caused by resistant Gram-positives.

Combination Coverage:

Beta-lactam antibiotics with beta-lactamase inhibitors (e.g., amoxicillin-clavulanate) provide extended coverage.

2. Treating Gram-Negative Infections:

• First-line Options:

Aminoglycosides (e.g., Gentamicin): Excellent for Gram-negative organisms but avoid in renal impairment.

Ciprofloxacin: Ideal for urinary tract infections and specific Gram-negative bacteria.

Aztreonam: Effective for Gram-negative infections with no Gram-positive coverage.

For Resistant Infections:

Polymyxins (e.g., Colistin): Used in severe, multi-drug resistant Gram-negative infections.

Carbapenems (e.g., Meropenem, Ertapenem): Broad-spectrum antibiotics reserved for serious Gram-negative infections.

For Community Infections:

Oral options like Fosfomycin can be used for uncomplicated UTIs.

3. Treating Anaerobic Infections:

Metronidazole: The gold standard for anaerobic infections.

Clindamycin: Useful when both Gram-positive and anaerobic coverage are needed.

Beta-lactam/Beta-lactamase Inhibitors (e.g., Piperacillin-Tazobactam): Broad-spectrum coverage for anaerobes and other pathogens.

4. Broad-Spectrum Antibiotics for Mixed Infections:

Use when both Gram-positive, Gram-negative, and anaerobes may be involved:

Carbapenems: Cover nearly all bacteria and are used in life-threatening infections.

Moxifloxacin: Covers Gram-positives, Gram-negatives, anaerobes, and atypicals.

Tigecycline: Effective for polymicrobial infections, including resistant organisms.

5. Key Points for Rational Use:

Start Narrow: Use targeted antibiotics based on clinical suspicion.

Save Broad-Spectrum Agents: Reserve carbapenems and polymyxins for severe or resistant infections.

Save Broad-Spectrum Agents: Reserve carbapenems and polymyxins for severe or resistant infections.

Consider Patient Factors: Adjust antibiotics based on allergies, kidney/liver function, and age.

Avoid Overuse: Overuse leads to antibiotic resistance – always de-escalate once culture results are available.

Special Considerations:

MRSA: Use Vancomycin or Linezolid.

Resistant Gram-negative infections: Use Polymyxins or Carbapenems.

Anaerobes: Start with Metronidazole.

Conclusion:

• Choosing the right antibiotic involves identifying the likely pathogen, using targeted agents first, and reserving broad-spectrum drugs for severe cases. This approach ensures effective treatment while minimizing resistance

CME INDIA Learning Edge

• Antibiotics are widely recognized for their benefits when used correctly, but inappropriate use remains a significant issue despite the recognized need for responsible application within clinical practice.

• Effective antibiotic treatment is crucial for universal healthcare, and it’s a global responsibility to ensure their appropriate use. Currently, the development of new antibiotics by pharmaceutical companies is hindered by scientific, regulatory, and financial challenges, which underscores the need for judicious antibiotic use.

The Global Alliance for Infections in Surgery “golden rules,”

1. Antibiotics should only be used when there is clear evidence of bacterial infection.
2. Use the narrowest spectrum antibiotic possible that is effective against the identified pathogen.
3. Optimize dosing to ensure efficacy while minimizing resistance development.
4. Duration of treatment should be as short as possible but long enough to achieve clinical cure.
5. Antibiotics should not be used for viral infections.
6. Prophylactic use should be limited to specific, evidence-based indications.
7. Regularly review and adjust antibiotic therapy based on clinical response and microbiological data.
8. Educate patients on the importance of completing their prescribed antibiotic course.
9. Monitor and manage local resistance patterns to inform treatment decisions.
10. 10.Promote antibiotic stewardship programs in healthcare settings to ensure these practices are followed.

References:

1. Sundvall PD, Skoglund I, Hess-Wargbaner M, Åhrén C. Rational antibiotic prescribing in primary care: qualitative study of opportunities and obstacles. BJGP Open. 2020 Oct 27;4(4):bjgpopen20X101079. doi: 10.3399/bjgpopen20X101079. PMID: 32994207; PMCID: PMC7606141.
2. Kasse GE, Humphries J, Cosh SM, Islam MS. Factors contributing to the variation in antibiotic prescribing among primary health care physicians: a systematic review. BMC Prim Care. 2024 Jan 2;25(1):8. doi: 10.1186/s12875-023-02223-1. PMID: 38166736; PMCID: PMC10759428.

---

Discover CME INDIA

• Explore CME INDIA Repository
• Examine CME INDIA Case Study
• Read History Today in Medicine
• Register for Future CMEs

---